Guidance for AVITA Medical, Inc. (RCEL)
| Period | Range | Estimate | Revenue Range | Revenue Estimate | Target | Details |
|---|---|---|---|---|---|---|
| 2026 | N/A | N/A | $80.00M – 85.00M | $124.20M | = Maintained | Details |
| 2025 | N/A | N/A | $70.00M – 74.00M | $93.83M | = Maintained | Details |
| 2025 | N/A | N/A | $100.00M – 106.00M | $91.45M | = Maintained | Details |
| 2025 | N/A | N/A | $100.00M – 106.00M | $89.70M | = Maintained | Details |
| 2024 | N/A | N/A | $78.50M – 84.50M | $71.98M | = Maintained | Details |
| Q4 2024 | N/A | N/A | $22.30M – 24.30M | $23.52M | = Maintained | Details |
| Q3 2024 | N/A | N/A | $19.00M – 20.00M | $21.56M | = Maintained | Details |
| Q1 2024 | N/A | N/A | $14.80M – 15.60M | $14.30M | = Maintained | Details |
| Q3 2023 | N/A | N/A | $13.00M – 14.00M | N/A | = Maintained | Details |
